Increased Risk of Superficial Fungal Infections Among Psoriasis Patients Receiving Systemic Treatment: A Nationwide Retrospective Population-Based Cohort Study
Ji-In Seo, Hasung Kim, Jung Kuk Lee, Hye-Jin Ahn, Ki-Heon Jeong, Min Kyung Shin · 2024
Read Increased Risk of Superficial Fungal Infections Among Psoriasis Patients Receiving Systemic Treatment: A Nationwide Retrospective Population-Based Cohort Study by Ji-In Seo, Hasung Kim, Jung Kuk Lee, Hye-Jin Ahn, Ki-Heon Jeong, Min Kyung Shin (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11621635.txt.
Description
Ji-In Seo and five colleagues present a 2024 research letter on an itchy side question in psoriasis care: do systemic treatments invite fungal skin infections? Arguments cut both ways, since immune-damping drugs could help fungi while psoriatic skin's fast turnover and antimicrobial peptides resist them. The team mined Korean national insurance claims for adults treated systemically between 2014 and 2018, matched against people without skin disease.
They tracked new fungal infections, from athlete's foot and ringworm to nail fungus and candida, per thousand person-years, and modeled risk by treatment class: biologics, classic immunosuppressants, and acitretin. Adjustments covered age, sex, and other illnesses. The nationwide scale gives the comparison a firm statistical footing that earlier, narrower studies lacked.
Catalog record
| CREATOR | Ji-In Seo, Hasung Kim, Jung Kuk Lee, Hye-Jin Ahn, Ki-Heon Jeong, Min Kyung Shin |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |